The anti-neprilysin market consists of drugs that inhibit neprilysin, a zinc metalloproteinase enzyme which degrades natriuretic peptides. Neprilysin inhibitor drugs are primarily used for the treatment of acute and chronic heart failure by preventing degradation of peptides like natriuretic peptides, which have beneficial cardiovascular effects. The global anti-neprilysin market i ... Read more

The anti-neprilysin market is primarily engaged in developing medicines that inhibit neprilysin, a zinc-dependent membrane-bound metalloprotease enzyme. Anti-neprilysin drugs play a vital role in the management of cardiovascular conditions by degrading natriuretic peptides that regulate blood pressure and sodium balance. The drugs have shown clinical benefits in reducing cardiovascular mortality and hospitalization for heart failure when used in combination with angiotensin receptor blockers ... Read more